rfhg_173692.1

Basic information about the TSS

---

TSS ID: rfhg_173692.1 Species: human Chr: chr15		Start: 48332243 End: 48332246 Strand: +
Source datasets	PRJNA615891
Protocol	TIF-seq2
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: DQ894375:0 DQ891191:0 GeneID: 1854 HGNC/MGI_ID: HGNC:3078 UniProt_ID: Nearer transcript ids and distances: KJ891075:5 CR541781:6 CR541720:6 M89913:-10 AB049113:-10 L11877:-12 U62891:-14 U31930:-19 ENST00000559540.5:-33 AK312122:-43 NM_001948.4:-46 AK291515:-82 ENST00000455976.6:-140 ENST00000558367.1:160 view more...

Gene_name: deoxyuridine triphosphatase Gene_symbol: DUT Gene_synonyms: dUTPase Gene_source: HGNC:3078

TATA-Box annotation

---

Distance to TSS:	47
Nearest PromoterID:	NM_001948
Entrez ID:	1854
Nearest Unigene:	Hs.527980
Nearest Refseq:	NM_001948
Nearest Ensembl:	ENSG00000128951
Gene Name:	deoxyuridine triphosphatase
Gene Alias:	dUTPase
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.750000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DUT p2@DUT p3@DUT p4@DUT
Sample		p1@DUT	p2@DUT	p3@DUT	p4@DUT
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	94.48	6.43	1.36	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	107.23	6.68	0.40	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	99.92	8.10	1.16	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	89.40	6.86	1.46	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	97.86	7.65	0.45	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	86.63	5.81	0.39	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	133.56	5.23	0.44	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	113.84	5.57	0.73	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	121.18	7.69	0.64	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	80.57	4.64	1.16	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	69.93	5.26	0.81	2.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	63.42	2.44	0.81	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	14.02	49.97	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	8.57	36.23	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.95	41.06	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.58	30.93	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.70	31.45	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.97	37.54	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.33	23.46	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.39	40.77	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.83	42.63	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.15	41.77	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.92	33.61	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.74	35.91	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.32	39.73	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.98	38.93	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.09	37.36	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	11.08	45.26	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.28	42.32	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	16.47	41.26	1.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	13.82	33.49	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	12.50	33.61	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.97	27.64	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	14.02	23.75	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	12.15	36.65	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	13.22	42.54	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	15.12	40.06	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.67	24.38	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	13.51	36.73	0.81	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.68	31.69	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.94	36.47	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.81	26.79	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	15.40	40.91	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	14.16	38.11	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.07	36.94	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	14.19	38.85	0.93	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	14.87	37.19	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.50	35.47	1.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.11	37.10	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	13.35	29.52	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	14.14	31.77	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	21.35	34.02	0.89	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.55	28.74	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	12.59	35.46	1.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	17.62	22.65	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.78	13.32	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	13.29	36.30	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	18.63	42.07	1.61	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.00	24.52	1.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	18.33	26.09	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	12.34	27.48	2.24	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	5.57	17.52	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.80	18.01	3.40	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.40	32.17	1.30	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.10	45.08	1.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	48.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.70	32.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.92	25.29	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.57	25.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	10.93	28.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.45	40.83	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	17.12	42.80	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	2.53	35.32	1.27	0.63
Adipocyte - breast, donor2	11327-117E4	8.50	26.47	1.76	1.12
Adipocyte - omental, donor1	11473-119C6	0.38	24.94	1.27	1.15
Adipocyte - omental, donor2	11474-119C7	1.49	23.17	2.24	0.75
Adipocyte - omental, donor3	11475-119C8	0.67	18.42	2.34	0.67
Adipocyte - perirenal, donor1	11476-119C9	0.00	15.95	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	16.49	0.00	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	2.71	20.77	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	0.70	27.11	0.35	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	3.13	28.16	0.00	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	6.43	16.73	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	8.08	22.86	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	9.99	26.45	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	0.32	23.00	1.21	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	4.20	18.07	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	0.53	14.40	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	1.67	15.02	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	2.91	23.71	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	1.26	23.86	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	1.31	15.71	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	0.61	14.01	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	111.38	9.50	0.88	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	78.53	7.53	1.08	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	25.16	17.97	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	68.90	23.03	0.72	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	28.45	13.39	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	30.41	25.06	1.03	0.21
Anulus Pulposus Cell, donor1	11248-116E6	26.43	24.72	0.23	0.11
Anulus Pulposus Cell, donor2	11463-119B5	15.43	15.67	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	23.81	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.95	28.22	1.74	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	21.40	0.00	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	4.18	23.32	1.79	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	3.79	40.47	0.00	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.96	25.74	1.98	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	9.10	21.44	1.62	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	7.28	25.24	0.97	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	21.38	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.52	23.35	1.51	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.08	21.04	2.18	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	25.08	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	5.44	28.33	1.98	1.32
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	28.66	2.73	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.73	33.02	1.36	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	3.21	20.90	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	5.48	25.70	2.27	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.82	22.18	2.67	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	29.26	6.83	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.81	23.22	2.65	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	15.61	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	28.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	3.77	22.81	2.57	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	33.56	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.37	25.24	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	4.55	20.11	1.14	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	21.80	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.13	22.23	2.28	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	2.57	23.94	1.92	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.39	23.23	0.26	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.22	22.05	0.94	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4.82	27.33	0.32	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	15.70	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	6.43	18.72	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	5.42	21.98	1.20	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	30.89	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	3.56	25.94	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	5.35	24.20	1.02	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	2.54	27.96	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.61	28.48	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.29	23.07	1.91	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.09	20.01	1.16	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	21.73	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	5.09	24.75	1.36	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	20.85	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	16.90	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.57	25.09	0.64	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.01	24.67	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	21.14	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	4.60	26.67	1.84	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	7.65	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.34	37.37	3.56	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.78	21.26	1.65	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	3.67	23.87	0.61	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	2.39	20.08	2.87	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	3.99	25.72	2.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	27.46	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.31	27.69	1.11	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	3.97	22.51	1.32	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.72	24.71	3.27	0.00
Astrocyte - cerebellum, donor1	11500-119F6	165.80	19.40	0.86	0.61
Astrocyte - cerebellum, donor2	11580-120F5	93.28	17.80	1.20	0.00
Astrocyte - cerebellum, donor3	11661-122F5	28.11	28.32	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	133.51	33.81	2.09	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	167.92	25.24	0.81	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	148.86	33.11	1.19	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	160.10	35.55	1.03	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	170.88	34.20	2.00	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	162.73	31.07	1.48	0.57
Basophils, donor1	12241-129G9	3.40	10.72	1.83	0.26
Basophils, donor2	12242-129H1	6.13	15.87	2.89	0.36
Basophils, donor3	12243-129H2	4.85	11.61	1.18	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	7.11	14.01	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	25.60	10.97	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	77.20	10.04	1.88	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	51.36	7.28	0.42	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	5.53	6.68	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	11.88	14.58	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	322.36	46.17	0.52	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	370.32	34.47	1.86	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	305.39	119.28	29.10	7.67
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	124.10	51.71	0.00
CD14+ Monocytes, donor1	11224-116B9	1.69	13.53	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	0.74	9.47	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	1.10	12.73	0.88	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	2.26	25.19	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	3.41	22.37	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	1.31	22.35	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	0.29	5.06	1.01	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	0.00	6.64	0.60	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	0.24	7.34	0.95	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.00	4.02	0.84	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.00	4.14	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.25	4.71	0.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.00	4.90	0.20	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.00	6.05	0.71	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.22	6.75	1.09	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.00	7.49	0.94	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.00	6.86	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	6.66	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.00	3.72	0.45	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.00	4.19	2.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.00	8.33	0.83	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.69	4.35	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.00	4.52	0.68	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	4.36	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.00	4.57	1.08	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.17	8.37	0.70	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.00	10.94	0.84	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.92	6.06	0.55	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.00	1.06	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.44	3.07	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.17	7.67	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.37	5.20	0.37	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.22	7.11	0.86	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	0.41	5.32	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.00	4.17	0.70	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.00	3.94	1.39	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	0.44	22.23	1.09	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	0.69	25.64	0.69	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	0.22	25.56	1.73	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	0.31	28.65	0.78	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	0.87	25.32	0.52	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	0.00	14.72	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	60.22	1.53	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	34.25	1.10	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	37.90	0.63	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	83.32	4.06	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	9.49	88.14	2.71	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	9.32	68.35	8.28	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	12.79	84.22	5.86	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	5.90	77.19	5.90	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.23	77.92	2.81	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	11.77	84.71	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	15.82	88.33	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	20.55	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	2.18	15.23	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	3.03	19.69	2.52	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	410.93	10.10	0.40	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	445.43	15.18	0.80	0.40
CD34+ Progenitors, donor1	11545-120B6	12.05	51.21	20.08	2.01
CD34+ Progenitors, donor2	11625-122B5	16.85	20.23	12.36	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	300.98	109.72	11.27	4.51
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	313.20	118.38	18.04	3.38
CD4+ T Cells, donor1	11225-116C1	1.79	23.57	2.86	1.43
CD4+ T Cells, donor2	11306-117C1	3.67	33.07	6.12	3.06
CD4+ T Cells, donor3	11382-118B5	3.96	29.89	5.18	3.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	38.29	26.80	2.55	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	30.10	32.12	1.80	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	16.67	43.12	4.89	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	2.37	78.70	9.01	3.79
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1.40	85.68	4.92	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	59.33	0.00	9.89
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	60.26	27.89	2.89	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	115.74	25.76	1.86	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	86.89	33.05	2.26	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	14.79	60.07	6.28	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	15.37	51.36	3.49	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	5.28	40.48	7.48	3.52
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	105.83	33.31	4.22	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	141.70	41.97	4.36	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	138.66	38.09	4.34	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1.63	73.15	6.80	2.99
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1.07	57.88	6.97	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	69.94	16.14	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	175.79	37.27	3.15	2.78
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	158.78	31.63	4.12	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	127.35	36.57	3.15	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	3.03	72.81	13.15	7.08
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	6.93	87.08	9.96	3.47
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	3.92	49.68	10.02	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	13.36	89.08	8.41	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	15.69	105.24	7.39	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	6.98	113.06	8.37	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	6.65	53.72	6.37	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	6.13	57.67	6.13	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	13.86	61.60	6.16	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	9.31	80.58	3.22	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	11.08	119.11	5.54	4.15
CD8+ T Cells, donor1	11226-116C2	2.95	27.83	3.93	2.95
CD8+ T Cells, donor2	11307-117C2	2.63	26.28	3.00	1.50
CD8+ T Cells, donor3	11383-118B6	2.52	41.41	3.79	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	67.21	10.32	1.38	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	68.78	10.54	1.44	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	70.31	12.59	0.55	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	71.75	12.91	1.20	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	57.60	12.24	0.96	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	61.39	10.91	1.14	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	94.52	11.30	0.65	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	96.60	9.48	1.58	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	88.41	11.02	1.64	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	96.60	14.19	1.51	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	85.12	13.07	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	86.32	15.45	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	34.14	9.63	1.75	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	35.52	9.11	0.91	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	38.04	8.20	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	64.11	12.97	1.08	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	67.61	8.92	0.00	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	61.75	10.61	1.41	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	87.47	9.51	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	97.81	8.61	1.23	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	74.70	8.66	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	68.84	8.80	1.15	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	67.00	9.46	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	80.94	12.10	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	46.57	11.24	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	29.38	13.29	3.50	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	29.05	9.02	1.00	3.01
Cardiac Myocyte, donor1	11525-119I4	0.00	27.42	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	53.86	20.75	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	28.41	27.78	0.42	0.11
Chondrocyte - de diff, donor1	11261-116G1	99.15	21.15	1.73	2.08
Chondrocyte - de diff, donor2	11338-117F6	7.82	21.68	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	14.45	49.15	1.71	1.25
Chondrocyte - re diff, donor2	11339-117F7	38.50	13.43	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	7.28	39.63	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	67.59	26.28	0.80	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	32.92	22.02	0.64	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	41.24	22.04	0.88	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	6.14	33.10	2.29	0.46
Corneal Epithelial Cells, donor1	11526-119I5	51.82	15.15	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	50.05	11.38	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	90.49	15.08	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	0.83	14.69	0.99	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.32	19.56	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	24.15	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.76	17.06	0.43	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.34	37.24	4.78	2.05
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	35.91	1.96	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.48	33.39	5.32	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	39.86	9.17	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	39.90	11.74	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	45.53	13.86	1.13	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	30.28	8.26	1.57	0.00
Endothelial Cells - Artery, donor1	11264-116G4	22.69	8.73	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	38.59	13.65	1.41	0.71
Endothelial Cells - Artery, donor3	11413-118E9	46.81	10.34	0.70	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	11.08	21.94	1.55	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	10.35	14.00	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	10.43	12.69	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	31.79	8.91	2.08	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	20.83	5.21	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	14.46	18.86	0.57	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	77.22	18.01	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	13.63	13.10	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	137.79	18.26	1.86	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	85.17	15.86	0.87	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	107.35	10.01	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	23.89	11.38	4.55	1.14
Endothelial Cells - Vein, donor2	11344-117G3	22.35	8.38	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	42.86	21.35	0.31	0.00
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	4.95	3.30	0.00
Eosinophils, donor3	12246-129H5	7.13	17.83	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	36.16	13.19	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	10.40	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	2.46	29.97	1.64	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	0.77	15.44	0.44	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.52	21.78	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	45.60	19.53	0.97	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	1.23	21.56	1.09	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	1.79	21.20	0.53	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	18.71	17.65	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	62.79	16.61	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	22.68	14.52	1.81	0.00
Fibroblast - Cardiac, donor2	11345-117G4	12.13	17.43	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	5.99	20.50	0.79	0.16
Fibroblast - Cardiac, donor4	11452-119A3	28.80	17.28	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	26.02	16.12	1.40	1.02
Fibroblast - Cardiac, donor6	11460-119B2	75.49	12.43	0.45	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	22.64	15.27	0.80	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	7.33	19.85	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	76.17	14.65	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	47.74	20.99	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	8.31	30.02	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	22.30	20.19	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	63.20	15.09	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	24.90	33.24	0.48	0.12
Fibroblast - Dermal, donor4	11450-119A1	175.33	15.94	0.23	0.23
Fibroblast - Dermal, donor5	11454-119A5	202.71	17.10	0.17	0.70
Fibroblast - Dermal, donor6	11458-119A9	239.41	17.22	0.16	0.97
Fibroblast - Gingival, donor1	11237-116D4	30.82	20.20	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	44.54	21.48	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	141.40	28.99	1.05	0.53
Fibroblast - Gingival, donor3	11394-118C8	7.35	16.34	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	13.51	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.98	24.67	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	157.77	19.18	0.31	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	106.29	17.71	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	21.53	12.35	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	90.23	21.64	0.73	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	103.76	18.41	0.27	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	153.46	14.92	0.66	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	3.37	29.05	0.44	0.29
Fibroblast - Lung, donor1	11270-116H1	23.11	9.52	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	68.64	11.94	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	73.44	20.89	0.21	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	44.98	7.50	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	4.20	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	11.20	9.52	0.00	0.56
Fibroblast - Mammary, donor1	11540-120B1	65.36	18.67	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	127.81	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	23.83	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	213.18	27.35	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	174.13	17.44	0.30	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	44.98	13.77	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	59.15	17.55	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	42.39	23.22	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	14.73	23.66	0.46	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	101.69	26.31	0.77	1.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	78.43	9.75	0.41	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	136.31	22.72	2.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	63.26	24.91	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	43.86	9.13	0.99	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	4.44	26.11	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	17.74	29.96	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	50.24	16.85	1.81	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	36.81	21.37	0.54	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	15.18	14.43	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	12.31	21.49	0.82	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	47.12	23.26	1.60	1.00
Fibroblast - skin normal, donor2	11561-120D4	31.95	15.37	1.51	0.90
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	49.26	14.51	0.91	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	9.36	29.99	0.66	0.75
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	12.99	33.51	0.68	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	14.78	12.15	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	41.86	15.87	1.81	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	99.69	19.74	0.84	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.88	17.25	0.63	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	22.16	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.07	31.38	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	15.43	24.44	2.25	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	26.54	21.60	2.08	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.19	14.31	2.30	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	275.60	24.50	2.30	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	271.18	13.40	5.10	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	333.19	25.96	4.28	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	80.80	54.88	2.48	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	57.08	34.48	1.60	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	202.49	32.10	3.76	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	81.42	48.64	3.70	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	52.84	37.51	1.96	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	285.23	24.32	3.98	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	78.86	21.48	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	57.75	19.70	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	94.56	12.09	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	31.59	13.88	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	40.70	11.21	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	50.42	6.71	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	28.98	16.89	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	26.03	15.07	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	23.17	8.52	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	49.64	22.75	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	51.50	19.87	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	35.97	22.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	58.27	19.96	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	70.06	24.26	1.02	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	53.74	13.83	0.53	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	28.72	16.75	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.72	14.86	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	44.48	28.11	0.22	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.74	19.63	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.54	14.70	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	36.93	28.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	31.36	27.90	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	43.03	22.85	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	23.81	24.69	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	29.03	33.33	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	44.09	20.75	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	15.39	27.58	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	33.26	27.48	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	29.42	23.57	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	29.80	24.63	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	40.77	25.19	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.49	18.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	27.21	23.29	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	28.98	19.17	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	44.39	16.85	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	57.22	22.64	0.31	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	48.71	22.67	0.78	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	22.23	24.13	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	19.54	22.49	0.37	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	15.13	21.71	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	4.96	13.88	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.28	20.97	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	21.99	28.04	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	5.59	9.91	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	129.39	11.55	1.79	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	66.41	25.42	0.46	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	144.23	20.46	1.43	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	383.97	18.46	1.56	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	406.03	20.06	1.98	1.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	305.32	13.84	1.84	3.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	121.27	27.22	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	172.52	15.09	3.87	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	213.39	16.04	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	158.23	20.87	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	152.65	19.20	4.23	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	180.78	12.77	2.47	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	133.29	13.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	151.29	15.94	1.40	2.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	141.20	20.92	0.98	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	113.24	23.49	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	150.45	23.22	1.59	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	145.38	21.40	0.68	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	169.14	54.29	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	147.18	24.05	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	114.84	19.83	1.18	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	91.48	22.02	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	130.89	26.51	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	125.42	22.09	1.15	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	179.13	36.88	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	135.31	23.45	1.15	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	111.48	19.88	2.28	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	121.73	31.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	95.16	23.50	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	100.99	21.91	1.37	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	67.09	42.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	72.66	30.20	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	91.13	25.95	0.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	84.95	30.52	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	92.93	36.29	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	69.56	31.57	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	83.81	30.69	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	79.93	42.01	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	39.94	19.31	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	61.03	24.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	89.54	28.05	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	72.79	28.14	0.97	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	28.53	7.99	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.15	18.30	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	55.10	15.74	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	1.90	23.47	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	3.34	23.81	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	190.31	24.14	1.97	1.62
Hep-2 cells mock treated, biol_rep2	11899-125E9	198.51	22.45	2.87	2.36
Hep-2 cells mock treated, biol_rep3	11900-125F1	200.43	19.79	1.82	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	196.43	22.95	2.08	1.97
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	186.97	20.85	1.93	2.36
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	181.70	20.67	1.72	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	195.40	23.41	1.62	2.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	168.46	20.41	2.74	1.89
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	185.50	18.58	3.52	2.24
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	59.88	10.63	1.12	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	41.55	19.91	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	44.80	19.40	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	17.44	14.53	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	90.04	12.41	1.22	0.00
Hepatocyte, donor1	11523-119I2	2.42	14.53	2.42	0.00
Hepatocyte, donor2	11603-120I1	2.15	15.08	2.15	0.00
Hepatocyte, donor3	11684-122I1	4.91	20.86	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	540.42	84.85	16.32	12.40
Intestinal epithelial cells (polarized), donor1	11246-116E4	36.18	6.47	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	34.30	21.27	0.69	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	63.68	12.74	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	13.35	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	108.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	56.76	13.84	2.77	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	45.05	5.01	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	154.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	76.89	7.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	9.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	89.34	22.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	78.36	18.34	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	68.98	10.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	79.41	22.50	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	78.71	12.20	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	62.86	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	106.45	17.01	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	78.88	12.37	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	62.67	23.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	43.47	24.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	59.74	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	81.49	21.19	1.63	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	46.18	10.92	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	28.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	95.64	20.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	76.63	12.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	130.28	19.35	2.83	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	72.56	17.23	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	73.71	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	96.85	36.59	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	90.20	22.87	2.54	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	55.48	22.32	1.91	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	65.62	34.63	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	56.41	36.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	89.59	33.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	41.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	110.81	21.30	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	66.73	31.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	62.86	31.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	59.11	33.38	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	68.61	15.49	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	90.78	22.69	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	53.19	31.39	5.23	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	56.24	40.50	11.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	59.24	13.94	6.97	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	54.41	24.54	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	33.25	29.09	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	42.74	34.20	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	72.71	22.09	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	66.56	24.20	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	31.04	6.21	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	35.95	21.15	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	2.77	14.20	0.41	0.08
Keratinocyte - epidermal, donor2	11349-117G8	10.54	8.78	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	88.41	20.26	0.66	0.28
Keratinocyte - oral, donor1	11251-116E9	43.14	26.34	0.68	0.00
Keratocytes, donor1	11527-119I6	16.16	9.28	1.03	1.03
Keratocytes, donor2	11607-120I5	125.38	15.23	1.17	1.17
Keratocytes, donor3	11688-122I5	0.40	16.40	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	35.17	6.59	0.00
Lens Epithelial Cells, donor1	11529-119I8	50.70	15.10	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	22.72	31.60	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	5.55	21.19	0.40	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	29.05	16.01	1.42	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	40.74	14.79	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	32.43	21.57	1.73	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	33.34	11.29	2.69	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	42.86	15.13	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	25.34	14.88	1.40	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	33.24	16.83	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	35.39	11.12	1.52	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	29.98	13.23	0.99	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	28.48	17.80	1.19	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	37.81	16.09	1.55	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	25.55	11.66	2.04	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	35.54	11.85	1.05	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	38.88	17.65	0.95	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	30.49	14.70	1.51	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	28.95	12.63	3.70	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	32.73	11.53	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	27.27	13.18	0.73	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	29.29	14.48	3.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	35.44	13.47	1.46	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	20.91	11.45	1.74	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	34.92	17.46	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	43.90	18.04	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	27.85	13.78	1.06	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	33.70	14.00	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	35.60	13.82	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	27.67	14.89	2.41	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	15.13	2.75	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	38.57	15.24	1.32	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	27.78	12.19	1.06	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	28.59	15.02	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	32.09	12.57	0.99	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	24.65	13.88	0.87	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	23.32	12.96	2.22	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	37.56	15.32	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	24.20	11.55	0.96	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	25.73	15.12	2.89	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	30.74	14.61	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	34.01	17.36	1.82	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	24.53	19.91	1.42	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	26.18	11.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	21.47	11.36	0.78	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	35.45	18.26	1.79	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	26.13	11.11	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	24.95	8.95	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	21.90	14.73	1.73	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	21.26	12.04	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	22.68	12.23	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	43.05	6.80	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	52.17	7.67	1.53	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	30.43	8.16	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	43.58	9.73	2.12	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	50.64	8.44	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	40.16	7.47	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	36.58	1.03	1.03	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	48.77	8.33	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	49.31	9.95	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	54.68	8.72	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	64.37	7.20	0.45	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	46.88	7.05	0.41	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	46.73	6.16	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	64.22	9.53	1.06	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	45.98	5.33	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	59.09	10.70	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	52.29	10.41	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	63.11	9.26	1.32	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	48.47	8.59	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	55.45	12.23	3.26	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	62.26	9.58	0.83	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	59.98	9.81	0.56	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	60.79	8.24	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	55.16	9.29	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	64.57	6.58	1.49	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	60.30	12.17	1.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	39.59	8.13	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	53.84	7.38	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	43.75	5.76	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	42.98	8.06	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	43.03	6.23	2.83	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	54.15	9.85	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	38.41	4.52	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	58.89	5.03	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	50.04	7.47	1.49	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	39.02	7.80	0.74	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	52.12	8.18	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	41.96	8.56	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	41.65	8.33	1.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	44.64	4.22	3.02	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	39.82	8.53	3.55	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	41.59	6.87	2.06	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	34.35	4.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	37.03	8.75	1.35	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	36.67	7.04	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	36.05	10.47	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	33.85	6.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	39.21	7.60	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	46.52	12.36	1.45	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	58.26	14.56	3.07	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	47.35	8.39	1.97	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	41.40	5.65	1.88	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	43.75	11.06	2.01	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	39.65	7.66	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	36.52	4.90	2.23	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	37.54	7.82	0.78	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	36.29	6.60	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	47.22	9.86	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	39.38	6.56	2.19	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	60.38	9.50	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	49.91	8.39	2.21	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	50.53	11.96	1.16	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	40.51	6.08	1.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	41.33	4.33	1.92	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	47.71	8.35	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	37.67	4.86	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	41.50	3.46	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	40.28	6.84	1.14	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	44.93	7.75	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	28.42	4.23	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	47.85	10.77	0.95	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	44.25	8.00	3.73	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	45.97	4.60	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	35.48	5.14	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	48.81	4.95	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	40.29	4.54	2.27	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	40.77	7.90	2.50	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	32.10	3.92	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	48.44	6.26	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	46.00	6.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	32.78	3.35	1.34	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	42.77	6.42	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.99	6.47	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	38.55	9.18	0.00	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	46.23	8.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	29.63	6.27	1.71	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	38.34	6.14	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	42.13	3.83	1.64	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	36.53	6.24	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	34.57	5.46	0.78	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	37.80	5.30	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	2.08	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	8.43	19.60	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	16.52	11.38	0.92	0.00
Macrophage - monocyte derived, donor3	11389-118C3	43.78	15.86	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	26.02	34.52	5.31	0.53
Mallassez-derived cells, donor2	11929-125I3	6.50	20.76	1.43	0.32
Mallassez-derived cells, donor3	11930-125I4	33.63	18.07	3.06	0.28
Mammary Epithelial Cell, donor1	11273-116H4	56.00	26.80	1.30	0.30
Mammary Epithelial Cell, donor2	11350-117G9	70.07	19.69	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	44.90	12.72	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	10.17	6.10	0.00	0.00
Mast cell, donor1	11563-120D6	27.90	24.66	1.19	0.43
Mast cell, donor2	11565-120D8	2.38	27.93	0.30	0.30
Mast cell, donor3	11566-120D9	1.35	33.77	0.68	0.00
Mast cell, donor4	11567-120E1	0.71	30.67	0.71	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	4.21	25.28	0.11	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	32.10	16.93	2.92	0.00
Mast cell, expanded, donor5	11939-126A4	44.17	32.58	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	50.21	27.45	2.34	0.17
Melanocyte - dark, donor1	11502-119F8	84.27	29.25	1.59	0.50
Melanocyte - dark, donor2	11582-120F7	49.84	21.46	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	139.59	28.40	0.36	0.36
Melanocyte - light, donor1	11274-116H5	11.28	10.11	0.00	0.47
Melanocyte - light, donor2	11351-117H1	15.01	11.60	0.00	0.00
Melanocyte - light, donor3	11423-118G1	23.42	8.67	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	159.83	22.80	0.52	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	113.76	19.90	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	24.37	26.52	0.54	0.00
Meningeal Cells, donor1	11493-119E8	133.74	10.05	0.12	0.62
Meningeal Cells, donor2	11573-120E7	61.62	11.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	151.76	15.16	0.57	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	136.87	30.80	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	0.10	20.73	0.40	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	23.65	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	113.81	11.77	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	99.75	18.66	2.87	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	5.51	15.88	1.27	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	16.08	16.08	1.51	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	213.60	17.36	0.44	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	184.11	7.31	2.92	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	153.45	13.30	1.02	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.73	15.93	0.42	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	15.61	14.87	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.68	22.37	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	1.48	15.43	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	9.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	99.26	24.98	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	95.35	25.52	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	9.38	21.89	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	180.70	21.77	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	0.27	32.62	1.06	0.27
Mesothelial Cells, donor2	12156-128G5	0.00	13.01	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	3.90	18.79	0.79	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	8.10	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6.65	16.50	0.49	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	11.48	11.78	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.06	10.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.75	8.09	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	6.76	13.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	12.10	7.91	0.93	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	7.11	12.60	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.86	10.69	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	3.54	8.85	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	8.36	14.44	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	3.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.73	10.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	5.52	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	5.07	9.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6.52	11.79	1.51	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.22	7.37	0.24	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.98	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.60	9.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.52	7.15	0.42	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.87	7.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	4.29	10.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.11	6.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.72	9.20	0.66	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.07	3.04	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	4.89	3.53	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.06	8.53	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	6.54	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.32	11.05	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.01	6.80	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.01	12.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.94	8.32	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	3.31	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2.56	1.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.99	6.94	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	2.09	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2.74	5.81	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.75	3.50	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.07	1.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	1.68	6.73	0.84	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.66	6.65	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.75	2.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.60	3.02	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.42	5.01	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.92	2.77	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.14	2.85	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.41	5.39	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.52	6.22	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.43	3.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	1.91	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.53	2.67	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	0.30	6.59	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.00	4.94	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.64	6.69	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	0.66	5.97	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.00	3.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.00	4.55	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	0.00	8.36	0.25	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.29	4.41	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.29	5.48	0.86	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	0.41	5.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.30	4.76	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	26.37	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	14.26	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	6.90	16.76	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	15.78	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.40	34.20	0.99	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	3.73	25.15	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1.13	22.91	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1.07	20.77	1.33	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.68	16.06	0.34	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.21	15.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.03	12.46	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1.56	17.11	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	24.05	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	19.32	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	8.08	10.10	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.28	21.50	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	16.34	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	7.63	18.44	1.27	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	30.77	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	24.17	6.04	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	19.57	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	14.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	8.62	19.60	1.94	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	0.52	22.99	2.09	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	24.03	15.35	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.10	10.43	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	36.89	12.55	0.38	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	62.24	11.17	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	18.36	11.56	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	75.34	22.05	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	21.35	23.02	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	27.20	16.50	0.23	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.89	14.86	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	26.91	15.35	0.84	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.36	17.37	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	1.89	17.05	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.99	20.63	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	5.23	19.11	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	7.84	20.41	1.28	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	3.18	20.16	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	0.00	27.01	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	0.33	13.13	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	0.16	18.21	0.81	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	3.70	13.58	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	1.41	28.83	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	1.38	23.90	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	1.93	24.10	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	0.00	11.38	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	10.11	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	2.45	20.50	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	0.00	25.40	0.85	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	0.95	17.33	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	1.72	29.62	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	1.67	14.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	0.90	15.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	0.40	17.46	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	4.64	26.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	0.38	29.51	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	0.98	18.25	0.98	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	0.00	8.72	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	1.81	14.93	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	0.88	13.23	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	2.66	28.59	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	0.00	23.81	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	0.38	16.08	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	0.30	35.69	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	3.54	16.36	0.88	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	0.00	18.97	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	15.33	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	1.22	35.36	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	0.00	17.00	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	0.00	19.67	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	0.00	27.69	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	0.00	14.74	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	15.17	0.00	5.06
Myoblast, donor1	11241-116D8	21.62	18.26	0.87	0.37
Myoblast, donor2	11322-117D8	30.49	19.37	1.34	0.19
Myoblast, donor3	11398-118D3	40.36	19.34	1.01	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	165.34	31.52	1.61	0.44
Natural Killer Cells, donor1	11230-116C6	3.38	23.99	1.85	0.62
Natural Killer Cells, donor2	11311-117C6	4.52	25.93	3.62	1.21
Natural Killer Cells, donor3	11387-118C1	3.68	23.01	3.68	1.29
Neural stem cells, donor1	11275-116H6	38.83	17.42	0.73	0.00
Neural stem cells, donor2	11352-117H2	46.22	13.48	1.93	0.00
Neurons, donor1	11494-119E9	105.82	25.03	3.41	1.14
Neurons, donor2	11574-120E8	51.30	27.08	0.44	0.44
Neurons, donor3	11655-122E8	91.26	36.18	3.29	1.64
Neutrophils, donor1	11233-116C9	0.93	1.86	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	2.44	3.05	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	6.29	26.12	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	16.61	18.56	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	8.42	12.84	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	6.19	30.15	1.24	0.41
Olfactory epithelial cells, donor2	11934-125I8	23.59	31.41	1.30	0.87
Olfactory epithelial cells, donor3	11935-125I9	10.44	33.60	1.48	0.57
Olfactory epithelial cells, donor4	11936-126A1	16.75	30.49	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	46.34	25.88	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	1.06	13.61	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	1.14	20.58	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.83	24.83	0.00	0.00
Osteoblast, donor1	11277-116H8	46.12	11.53	0.00	0.00
Osteoblast, donor2	11354-117H4	71.64	18.26	0.70	0.00
Osteoblast, donor3	11426-118G4	45.68	24.17	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	47.17	25.52	0.59	0.17
Pericytes, donor1	11491-119E6	6.68	11.35	0.22	0.00
Pericytes, donor2	11571-120E5	8.83	13.58	0.23	0.23
Pericytes, donor3	11652-122E5	34.59	18.51	0.20	0.00
Perineurial Cells, donor1	11499-119F5	59.45	28.71	0.57	0.00
Perineurial Cells, donor2	11579-120F4	49.78	24.38	0.92	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	1.27	18.17	2.55	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	0.98	17.39	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1.68	18.89	0.65	0.39
Placental Epithelial Cells, donor1	11278-116H9	25.59	17.22	0.72	0.24
Placental Epithelial Cells, donor2	11355-117H5	16.63	14.42	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	31.61	23.76	0.79	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	4.43	19.30	1.27	0.63
Preadipocyte - breast, donor1	11467-119B9	0.94	24.20	2.06	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	7.57	22.58	0.91	0.39
Preadipocyte - breast, donor2	11328-117E5	3.83	30.17	1.58	0.23
Preadipocyte - omental, donor1	11468-119C1	0.75	29.20	1.81	2.02
Preadipocyte - omental, donor2	11329-117E6	6.55	28.37	1.75	2.62
Preadipocyte - omental, donor3	11403-118D8	0.86	30.37	1.72	0.72
Preadipocyte - perirenal, donor1	11469-119C2	1.97	11.81	2.95	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	19.35	6.76	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	116.69	17.71	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	58.58	26.73	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	121.09	17.23	0.84	0.47
Preadipocyte - visceral, donor2	11357-117H7	34.51	15.19	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	91.22	11.60	0.73	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	44.35	8.75	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	4.87	19.50	0.95	0.14
Prostate Epithelial Cells, donor3	11404-118D9	0.12	10.47	0.31	0.06
Prostate Stromal Cells, donor1	11254-116F3	69.71	14.47	1.03	0.23
Prostate Stromal Cells, donor2	11332-117E9	63.29	22.59	1.08	0.72
Prostate Stromal Cells, donor3	11405-118E1	4.28	25.44	0.94	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	66.06	20.07	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	46.51	20.17	0.42	0.07
Renal Epithelial Cells, donor1	11517-119H5	109.56	17.75	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	96.74	14.23	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	42.24	25.20	0.42	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	70.13	14.30	6.13	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	74.79	10.65	1.89	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	107.01	16.65	1.33	2.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	17.97	23.96	2.00	2.00
Renal Mesangial Cells, donor1	11518-119H6	72.41	16.07	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	58.94	23.20	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	23.58	17.48	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	115.42	22.82	0.54	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	55.24	18.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	104.72	21.60	0.96	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	80.38	22.82	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	35.81	26.72	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	118.35	13.38	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	7.78	18.82	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	4.68	31.67	0.13	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	37.52	25.02	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	46.23	18.71	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	31.32	8.12	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	55.13	9.23	0.65	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	52.23	17.87	0.79	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	72.61	18.29	1.12	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	66.86	18.48	0.62	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	51.40	18.65	0.23	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	44.84	16.87	1.39	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	45.04	10.82	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	49.92	16.49	0.45	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	66.48	21.86	0.54	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	45.76	15.35	0.72	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	44.21	13.74	0.54	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	48.68	18.59	0.44	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	45.12	9.94	0.76	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	44.07	13.60	0.37	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	53.74	14.28	1.13	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	46.71	9.29	1.06	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	45.46	13.53	0.58	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	48.12	17.76	0.95	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	44.53	10.79	0.96	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	42.05	11.77	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	48.36	14.70	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	43.94	10.94	1.09	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	44.52	13.24	0.61	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	46.21	17.06	0.94	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	56.85	11.56	1.18	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	55.16	15.08	0.79	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	56.12	18.47	1.17	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	49.97	14.93	0.41	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	53.09	12.61	0.88	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	39.48	18.38	1.04	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	45.62	11.57	1.35	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	41.89	13.96	0.34	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	49.36	15.62	1.35	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	45.74	11.35	1.03	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	45.54	13.44	1.23	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	45.64	14.28	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	48.06	11.42	0.17	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	48.68	17.02	0.59	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	36.25	16.53	0.80	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	44.66	12.58	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	54.29	21.19	0.95	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	37.69	18.54	1.21	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	58.95	18.36	0.57	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	47.51	21.31	0.35	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	42.61	18.44	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	61.93	14.69	0.86	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	60.40	25.91	1.60	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	53.54	24.95	2.43	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	83.79	21.40	0.90	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	47.27	30.31	1.13	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	57.51	30.55	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	34.12	12.99	0.83	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	61.26	20.92	0.85	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	58.90	24.04	0.00	0.00
Schwann Cells, donor1	11498-119F4	144.63	17.87	0.38	0.56
Schwann Cells, donor2	11578-120F3	159.91	13.61	0.00	0.00
Schwann Cells, donor3	11659-122F3	70.33	21.91	0.44	0.22
Sebocyte, donor1	11220-116B5	13.15	18.08	0.00	0.00
Sebocyte, donor2	11301-117B5	13.33	13.33	0.00	0.00
Sebocyte, donor3	11378-118B1	7.01	20.61	0.21	0.00
Sertoli Cells, donor1	11255-116F4	24.85	24.85	0.00	0.00
Sertoli Cells, donor2	11333-117F1	5.65	31.07	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	7.04	15.22	0.09	0.00
Skeletal Muscle Cells, donor2	11358-117H8	0.00	16.63	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	105.34	20.06	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	192.28	17.59	0.79	0.00
Skeletal Muscle Cells, donor5	11455-119A6	168.27	19.18	1.49	0.30
Skeletal Muscle Cells, donor6	11459-119B1	216.08	19.55	0.77	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	83.29	32.89	0.63	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	95.32	26.40	1.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	172.33	23.61	0.60	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	20.81	20.56	0.34	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	71.65	10.13	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	23.39	10.73	0.55	0.55
Skin - palm, donor1	10286-104F7	0.00	13.43	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.76	16.87	1.59	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	3.27	26.99	13.90	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	16.36	12.85	0.65	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	0.56	17.10	1.95	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	1.41	14.07	1.27	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	19.66	50.75	8.03	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	0.07	12.89	0.97	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6.48	11.42	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	2.67	8.00	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	15.28	15.87	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	10.39	9.28	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.21	14.18	1.18	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	14.68	27.04	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	3.00	25.02	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	4.39	14.37	1.06	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	30.81	32.14	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	9.47	18.05	1.66	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	39.07	17.26	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	34.26	20.38	0.89	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	8.97	16.94	1.14	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	58.89	16.92	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	4.57	13.70	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.92	15.91	1.01	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	18.36	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	13.35	13.83	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	43.36	12.98	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	40.25	14.42	0.86	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	61.82	18.47	0.94	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.29	12.22	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	12.93	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	21.82	11.06	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	115.05	13.31	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	15.55	21.67	0.24	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	1.91	14.19	0.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	5.92	18.89	0.91	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	10.87	12.08	2.42	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	228.37	8.74	0.53	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	61.52	11.32	0.53	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	17.53	19.28	0.38	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.83	25.37	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.80	17.49	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.75	16.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	23.26	10.34	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	27.90	12.09	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	5.05	12.12	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	2.82	14.10	0.94	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.40	12.39	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	150.04	14.08	0.33	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	15.42	14.48	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.76	11.80	0.29	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	42.32	22.44	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	54.15	11.28	0.38	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	94.75	19.98	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	9.89	24.30	0.34	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	8.10	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.38	11.74	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	3.31	12.81	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	82.51	9.07	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	2.14	29.54	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	1.85	14.54	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.53	9.67	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	1.80	15.81	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.54	12.21	1.42	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	102.01	14.18	1.18	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	9.90	16.76	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	5.19	26.75	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	2.51	33.44	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	2.29	36.67	0.46	0.46
Synoviocyte, donor1	11291-117A4	9.26	17.84	0.17	0.00
Synoviocyte, donor2	11368-117I9	11.90	50.29	2.85	1.84
Synoviocyte, donor3	11440-118H9	8.94	33.51	0.45	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	202.96	18.94	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	27.75	5.95	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	72.47	12.74	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	32.26	10.97	0.36	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	27.45	8.12	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	19.47	6.30	1.72	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	3.57	31.13	0.37	0.00
Urethra, donor2	10319-105A4	3.60	23.38	0.00	0.00
Urothelial Cells, donor1	11520-119H8	9.56	18.06	0.53	0.00
Urothelial Cells, donor2	11600-120H7	8.81	14.42	0.40	0.00
Urothelial Cells, donor3	11681-122H7	8.94	17.42	0.69	0.00
Urothelial cells, donor0	11216-116B1	9.14	22.29	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	3.56	8.90	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	1.43	25.73	1.43	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	2.05	20.54	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	3.79	28.92	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	2.91	23.24	1.16	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	1.04	10.41	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	1.84	16.52	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	1.83	22.82	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	82.16	29.24	0.62	0.12
Wilms' tumor cell line:HFWT	10597-108E3	8.80	14.08	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	47.20	4.19	0.00	0.00
achilles tendon, donor2	10292-104G4	16.53	14.47	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	185.61	29.83	0.76	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	440.44	52.47	3.95	2.79
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	313.03	33.59	1.31	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	363.00	45.17	6.53	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	428.93	15.74	1.69	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	348.73	109.34	8.46	2.33
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	149.44	31.58	1.91	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	273.64	29.52	3.97	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	167.43	58.80	7.35	4.08
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	285.01	44.27	13.20	4.66
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	327.15	16.19	5.70	2.76
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	288.64	58.51	11.70	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	253.53	29.74	0.46	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	364.53	25.37	1.04	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	286.40	29.22	2.34	1.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	115.73	22.31	2.32	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	162.86	44.00	2.88	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	235.12	23.94	2.46	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	266.69	26.88	3.41	2.99
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	240.82	31.85	3.64	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	291.49	29.85	4.09	2.41
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	543.93	37.87	10.25	5.79
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	259.50	14.68	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	204.40	13.01	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	414.70	42.94	2.26	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	187.54	39.25	7.85	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	97.47	20.62	9.37	1.87
adenocarcinoma cell line:IM95m	10796-110I4	49.93	32.97	0.47	0.47
adipose tissue, adult, pool1	10010-101C1	1.71	23.11	0.47	0.00
adipose, donor1	10184-103D4	54.54	41.05	6.45	1.17
adipose, donor2	10185-103D5	15.41	42.17	1.22	0.41
adipose, donor3	10186-103D6	44.66	39.21	3.00	1.36
adipose, donor4	10187-103D7	104.88	15.60	3.47	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	80.01	24.78	0.32	0.16
adrenal gland, adult, pool1	10081-102A9	0.00	32.74	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	135.41	49.23	0.80	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	91.83	28.23	1.43	0.36
amniotic membrane cells, donor1	12235-129G3	0.70	48.69	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	146.74	63.90	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	0.59	39.18	0.29	0.00
amygdala - adult, donor10196	10167-103B5	1.19	28.46	9.49	2.37
amygdala, adult, donor10252	10151-102I7	0.41	30.21	1.62	0.20
amygdala, newborn, donor10223	10360-105E9	0.32	20.01	0.65	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	8.02	65.83	0.38	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	234.08	20.96	0.66	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	80.50	51.11	0.00	0.33
aorta, adult, pool1	10052-101G7	0.59	34.13	0.20	0.00
appendix, adult	10189-103D9	56.67	36.48	1.16	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	42.65	36.46	0.34	0.00
artery, adult	10190-103E1	0.00	27.17	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	81.27	45.20	0.72	0.14
b cell line:RPMI1788	10427-106D4	132.05	18.74	0.45	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	4.16	34.40	0.83	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	81.37	15.78	0.50	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	53.23	61.09	1.67	1.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	143.16	39.71	6.71	7.83
bladder, adult, pool1	10011-101C2	0.43	19.45	0.33	0.00
blood, adult, pool1	10053-101G8	0.00	22.15	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	41.96	19.70	1.71	2.57
bone marrow, adult	10192-103E3	19.57	22.94	1.35	0.00
brain, adult, donor1	10084-102B3	0.00	46.13	2.05	0.00
brain, adult, pool1	10012-101C3	0.22	41.20	1.67	0.22
brain, fetal, pool1	10085-102B4	5.34	37.40	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	34.69	12.55	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	54.80	58.17	1.50	1.37
breast, adult, donor1	10080-102A8	0.63	28.41	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	82.83	24.01	0.51	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	119.67	26.28	1.24	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	68.61	19.34	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	108.70	35.83	5.08	0.97
carcinoid cell line:NCI-H1770	10703-109H1	196.53	50.78	2.82	0.94
carcinoid cell line:NCI-H727	10735-110B6	37.08	14.99	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	164.79	32.96	1.27	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	140.54	48.98	0.53	0.27
caudate nucleus - adult, donor10196	10177-103C6	1.15	41.45	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	0.33	45.85	3.35	0.17
caudate nucleus, adult, donor10258	10379-105H1	0.76	63.42	3.82	0.00
caudate nucleus, newborn, donor10223	10354-105E3	1.10	21.61	2.20	0.00
cerebellum - adult, donor10196	10173-103C2	0.00	43.70	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	0.21	33.95	2.99	0.64
cerebellum, adult, pool1	10083-102B2	2.41	53.81	1.38	0.34
cerebellum, newborn, donor10223	10357-105E6	1.66	32.38	0.83	0.83
cerebral meninges, adult	10188-103D8	0.00	42.86	1.51	0.25
cerebrospinal fluid, donor2	10294-104G6	13.16	19.73	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	141.05	60.96	5.18	2.16
cervical cancer cell line:ME-180	10553-107I4	66.95	39.44	2.32	0.99
cervix, adult, pool1	10013-101C4	2.83	35.91	0.63	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	18.53	77.89	1.25	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	10.45	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	50.70	17.90	0.62	0.00
choriocarcinoma cell line:SCH	10785-110H2	47.56	31.79	0.49	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	40.79	14.94	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	1.42	44.73	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	29.63	19.19	0.60	0.10
chorionic membrane cells, donor3	12240-129G8	2.75	28.02	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	459.46	36.35	15.15	6.06
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	183.45	18.06	1.73	1.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	172.33	38.86	8.03	2.53
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	149.46	11.81	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	155.04	13.30	1.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	116.87	8.96	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	175.50	8.24	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	252.02	25.54	2.87	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	52.80	19.20	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	65.24	20.82	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	105.25	9.70	0.37	0.55
colon carcinoma cell line:COLO-320	10420-106C6	93.50	29.27	1.14	0.00
colon, adult, donor1	10082-102B1	21.42	41.65	0.00	0.00
colon, adult, pool1	10014-101C5	5.41	27.61	0.59	0.12
colon, fetal, donor1	10070-101I7	8.03	33.37	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	91.67	59.59	59.59	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	125.18	100.15	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	85.84	14.87	1.70	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	146.71	13.73	1.06	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	164.28	13.11	1.83	0.56
corpus callosum, adult, pool1	10042-101F6	0.55	46.44	0.77	0.11
cruciate ligament, donor2	10295-104G7	15.40	19.45	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	2.41	36.92	0.80	0.00
diencephalon, adult	10193-103E4	0.48	41.28	0.72	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	258.08	25.03	4.13	2.07
ductal cell carcinoma cell line:KLM-1	10438-106E6	61.29	15.64	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	23.59	21.42	0.96	0.24
ductus deferens, adult	10196-103E7	0.50	40.37	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	12.96	38.89	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	17.66	13.24	0.74	1.47
dura mater, adult, donor1	10041-101F5	17.34	18.58	0.58	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	104.60	7.99	2.66	2.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	149.17	12.47	1.15	2.15
embryonic pancreas cell line:1B2C6	10604-108F1	38.85	15.42	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	9.69	26.03	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	23.77	15.75	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	13.13	15.76	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	23.80	17.77	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	17.58	26.10	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	13.67	13.99	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	119.50	15.45	0.89	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	165.64	15.84	0.11	0.22
epididymis, adult	10197-103E8	6.70	39.98	0.84	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	74.33	45.77	1.24	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	26.74	9.44	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	158.57	58.32	8.52	5.50
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	160.03	69.68	10.14	5.31
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	172.97	70.58	8.85	4.37
esophagus, adult, pool1	10015-101C6	9.56	33.02	0.64	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	3.63	35.57	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	2.41	26.56	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	2.10	14.73	4.21	0.00
eye - muscle medial, donor2	10299-104H2	0.00	14.88	2.98	0.00
eye - muscle superior, donor2	10297-104G9	16.05	29.81	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	34.98	13.12	2.91	0.00
eye, fetal, donor1	10054-101G9	2.80	36.10	0.76	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	69.63	42.44	1.92	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	176.40	18.76	0.00	1.19
frontal lobe, adult, pool1	10040-101F4	0.09	42.69	1.88	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	76.86	20.42	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	9.69	24.32	0.46	0.00
gall bladder, adult	10198-103E9	6.04	32.35	0.97	0.24
gamma delta positive T cells, donor1	11937-126A2	9.13	67.11	3.22	0.00
gamma delta positive T cells, donor2	11938-126A3	11.20	46.31	3.36	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	9.93	35.48	2.53	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	13.93	15.28	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	95.91	41.64	0.82	0.33
gastric cancer cell line:GSS	10560-108A2	94.27	35.69	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	43.64	17.59	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	8.84	15.83	0.46	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	22.25	21.83	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	79.31	41.15	1.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	55.73	25.23	0.84	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	60.11	23.45	0.56	0.84
glioblastoma cell line:T98G	10485-107A8	146.80	27.26	0.77	0.77
glioma cell line:GI-1	10413-106B8	15.52	29.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	0.00	40.82	2.19	0.73
globus pallidus, adult, donor10252	10161-103A8	1.71	44.18	1.95	0.49
globus pallidus, adult, donor10258	10367-105F7	0.00	73.94	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	2.66	27.71	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	171.30	78.31	53.84	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	207.64	54.64	65.57	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	376.31	78.40	26.13	0.00
granulosa cell tumor cell line:KGN	10624-108H3	29.12	17.60	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	176.76	14.69	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	171.47	15.09	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	196.45	10.95	1.29	0.00
hIPS, biol_rep1	14380-156B6	228.53	11.50	0.00	0.00
hIPS, biol_rep2	14381-156B7	261.32	13.03	0.69	0.00
hIPS, biol_rep3	14382-156B8	27.59	26.48	4.41	3.31
hairy cell leukemia cell line:Mo	10712-109I1	135.05	33.04	5.17	1.44
heart - mitral valve, adult	10205-103F7	1.49	35.88	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	1.31	31.12	0.78	0.00
heart - tricuspid valve, adult	10207-103F9	1.67	29.98	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	12.45	24.08	0.41	0.00
heart, adult, diseased, donor1	10051-101G6	1.28	23.85	0.85	0.43
heart, adult, pool1	10016-101C7	1.38	46.00	1.15	0.00
heart, fetal, pool1	10046-101G1	11.60	42.61	0.92	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	1.23	13.88	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	8.32	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	101.88	21.10	0.22	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	101.35	22.33	0.73	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	92.26	20.82	0.51	0.20
hepatoma cell line:Li-7	10484-107A7	30.03	21.58	0.22	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	368.94	18.69	2.01	2.91
hippocampus - adult, donor10196	10169-103B7	0.95	35.96	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	0.20	40.82	2.25	0.00
hippocampus, adult, donor10258	10374-105G5	1.49	23.40	2.99	0.00
hippocampus, newborn, donor10223	10363-105F3	0.00	19.74	1.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	347.29	26.24	3.66	4.27
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	283.14	16.30	2.16	1.96
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	299.09	22.60	4.06	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	72.17	37.78	1.69	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	80.82	42.60	1.03	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	90.73	33.79	3.04	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	48.46	33.87	2.63	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	45.67	35.11	1.72	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	55.05	35.45	2.09	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	107.27	39.54	2.84	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	89.52	41.63	0.80	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	101.67	58.58	4.04	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	233.79	14.87	2.19	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	249.09	12.28	2.46	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	372.67	13.96	3.49	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	54.41	41.05	1.72	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	57.13	34.01	1.31	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	54.97	33.98	2.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.06	28.26	0.75	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.46	29.56	1.36	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	13.16	25.69	1.25	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	27.43	47.85	2.45	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.10	40.93	0.58	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.60	38.56	3.89	2.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	196.38	20.69	2.59	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	193.42	21.97	1.71	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	238.05	24.50	4.08	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	63.02	33.10	2.46	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	65.57	39.59	1.90	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	60.22	35.71	4.24	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	32.58	34.65	2.59	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	31.22	36.53	3.32	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	28.99	32.84	2.57	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	51.13	30.42	2.56	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	62.85	46.95	3.03	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	60.15	44.70	1.34	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	198.52	25.36	1.21	1.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	252.24	19.61	3.57	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	213.17	36.10	3.41	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	52.26	36.98	4.28	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	139.89	48.80	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	61.89	37.40	4.63	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	42.14	30.65	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	31.48	30.76	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	29.18	18.15	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	59.67	31.03	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	55.52	36.43	1.63	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	54.96	32.87	1.89	0.00
immature langerhans cells, donor1	11904-125F5	23.97	15.98	1.21	0.97
immature langerhans cells, donor2	11905-125F6	47.53	27.72	1.58	0.00
insula, adult, pool1	10039-101F3	0.28	37.29	1.61	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	38.37	32.19	0.33	0.33
kidney, adult, pool1	10017-101C8	1.70	26.93	0.90	0.10
kidney, fetal, pool1	10045-101F9	10.68	28.58	0.57	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	1.99	33.94	0.43	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	6.77	47.14	2.07	1.24
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	43.86	6.79	0.92	0.55
left atrium, adult, donor1	10079-102A7	3.81	22.88	0.54	0.00
left ventricle, adult, donor1	10078-102A6	5.56	29.33	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	111.63	10.94	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	3.23	10.42	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	2.72	19.57	3.26	1.63
leiomyoma cell line:15425	10571-108B4	8.98	14.57	0.73	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	57.14	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	21.96	32.41	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	103.18	27.51	4.25	1.53
liposarcoma cell line:KMLS-1	10782-110G8	13.75	22.96	0.94	0.47
liposarcoma cell line:SW 872	10726-110A6	42.64	18.03	1.46	0.85
liver, adult, pool1	10018-101C9	0.16	13.61	0.49	0.81
liver, fetal, pool1	10086-102B5	46.09	10.35	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	0.15	32.08	2.19	0.29
locus coeruleus, adult, donor10252	10165-103B3	0.18	38.39	1.66	0.37
locus coeruleus, adult, donor10258	10375-105G6	0.56	49.66	1.41	0.28
locus coeruleus, newborn, donor10223	10362-105F2	0.42	22.29	2.52	0.00
lung adenocarcinoma cell line:A549	10499-107C4	7.33	18.27	0.69	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	22.75	29.64	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	40.34	14.10	0.00	0.00
lung, adult, pool1	10019-101D1	4.49	23.63	0.59	0.12
lung, fetal, donor1	10068-101I5	4.00	30.25	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	2.75	40.32	0.00	0.46
lymph node, adult, donor1	10077-102A5	10.89	19.88	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	103.45	26.52	1.75	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	365.54	39.69	1.81	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	29.73	22.09	0.85	0.00
mature adipocyte, donor1	12231-129F8	0.00	53.72	1.33	0.89
mature adipocyte, donor2	12232-129F9	0.42	52.09	0.83	0.42
mature adipocyte, donor3	12233-129G1	0.00	45.99	0.95	0.24
mature adipocyte, donor4	12234-129G2	0.00	35.01	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	17.87	33.59	2.14	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	0.00	55.27	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	0.74	35.13	1.66	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	0.00	53.05	2.22	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	0.43	19.19	2.99	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	0.68	42.36	3.54	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	0.21	36.08	2.33	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	23.12	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	43.06	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	1.08	20.46	3.23	1.08
medulla oblongata - adult, donor10196	10174-103C3	0.00	39.59	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	0.15	38.24	1.24	0.15
medulla oblongata, adult, pool1	10038-101F2	0.33	28.24	1.55	0.16
medulla oblongata, newborn, donor10223	10361-105F1	1.04	23.96	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	141.26	44.73	1.33	0.66
medulloblastoma cell line:ONS-76	10759-110E3	93.42	9.90	0.37	0.00
melanoma cell line:COLO 679	10514-107E1	16.39	10.49	0.29	0.43
melanoma cell line:G-361	10465-106H6	12.76	48.32	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	5.07	31.30	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	331.32	45.82	4.41	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	107.58	26.70	2.85	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	71.81	20.71	0.77	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	21.63	19.45	0.91	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	57.97	13.25	0.41	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	9.27	17.84	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	5.78	14.44	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.94	26.37	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	0.34	25.75	0.51	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	9.32	19.55	0.69	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	44.17	21.09	1.19	1.33
mesenchymal precursor cell - cardiac, donor4	11755-123G9	50.64	20.26	1.08	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	26.18	15.93	0.57	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	0.33	22.73	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	21.86	19.51	0.83	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	39.45	12.57	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	8.78	20.42	0.41	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	1.80	13.30	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	4.66	21.31	0.31	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	1.82	8.89	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	47.41	13.43	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.15	19.28	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	6.21	20.31	1.05	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	4.05	22.09	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.30	8.58	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	129.67	33.26	2.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	31.51	27.86	0.91	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	30.95	23.79	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	26.18	23.82	2.36	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	25.88	21.26	0.62	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	23.30	19.77	0.24	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	31.81	23.69	1.02	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	33.40	20.83	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	30.12	19.46	0.93	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	36.63	25.96	2.31	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	33.69	29.23	1.56	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	30.04	18.51	0.24	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.93	15.40	0.73	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.17	22.82	1.68	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	33.16	19.24	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	36.51	27.06	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	30.08	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	15.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	28.26	28.58	0.65	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	20.37	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	43.71	30.39	1.07	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	23.72	25.35	0.00	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	29.15	30.71	1.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	44.07	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	26.82	24.84	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	33.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.94	29.65	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	23.15	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	33.57	25.97	3.80	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.28	36.90	1.03	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	32.24	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	23.95	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	58.55	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.85	33.41	1.22	2.85
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	5.56	41.31	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	0.59	35.96	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	0.62	44.89	0.94	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1.34	40.10	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1.18	33.11	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	38.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	0.00	37.86	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	0.00	30.68	2.47	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	0.00	31.40	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	0.64	35.62	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	0.40	36.27	1.61	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	41.43	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	0.00	35.48	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	0.00	31.56	1.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	27.11	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	0.00	30.48	1.65	4.12
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	1.98	48.42	1.59	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	0.97	40.24	0.32	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	1.02	37.69	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	6.19	21.66	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	17.48	28.82	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	42.63	25.95	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	106.84	34.19	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	104.70	19.11	1.13	0.21
mesothelioma cell line:Mero-25	10850-111F4	49.48	25.87	3.18	1.82
mesothelioma cell line:Mero-41	10851-111F5	73.10	34.23	0.24	0.24
mesothelioma cell line:Mero-48a	10852-111F6	24.36	19.04	0.66	0.44
mesothelioma cell line:Mero-82	10853-111F7	39.68	19.18	1.84	0.00
mesothelioma cell line:Mero-83	10854-111F8	64.68	32.68	1.53	0.68
mesothelioma cell line:Mero-84	10855-111F9	80.89	13.14	1.01	0.25
mesothelioma cell line:Mero-95	10856-111G1	54.04	36.44	0.83	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	55.33	10.77	0.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	85.25	23.53	2.17	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	124.87	44.41	1.37	0.17
mesothelioma cell line:NCI-H28	10845-111E8	73.80	30.03	0.00	0.00
mesothelioma cell line:No36	10857-111G2	144.51	37.19	1.30	0.98
mesothelioma cell line:ONE58	10858-111G3	15.99	8.13	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	0.38	4.80	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	0.00	4.88	0.37	0.00
migratory langerhans cells, donor3	11903-125F4	0.00	13.28	1.62	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.32	36.57	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	93.25	24.80	0.64	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	45.38	9.21	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	110.75	24.55	1.33	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	559.37	68.74	1.29	0.55
myeloma cell line:PCM6	10474-106I6	17.79	27.08	0.59	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	45.66	7.61	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	107.09	42.76	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	0.00	17.94	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	0.07	14.19	0.37	0.07
nasal epithelial cells, donor2	12227-129F4	5.52	13.25	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	71.78	27.15	2.07	1.61
neuroblastoma cell line:NB-1	10539-107G8	280.44	45.09	2.99	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	21.72	21.72	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	229.58	51.43	1.30	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	65.00	20.40	1.19	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	78.56	38.01	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	153.96	19.12	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	55.95	2.54	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	21.56	15.97	1.06	1.06
neutrophil PMN, donor1	12133-128D9	44.62	44.62	14.87	0.00
neutrophil PMN, donor2	12137-128E4	26.56	26.56	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	9.47	9.47	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	321.50	58.01	2.37	1.69
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	166.51	28.02	3.20	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	28.85	35.27	1.60	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	16.82	21.55	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	0.09	35.34	1.03	0.09
occipital cortex - adult, donor10196	10172-103C1	0.00	53.57	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	1.34	44.01	1.88	0.27
occipital cortex, newborn, donor10223	10355-105E4	0.36	14.19	1.09	0.36
occipital lobe, adult, donor1	10076-102A4	1.05	38.84	1.31	0.26
occipital lobe, fetal, donor1	10073-102A1	8.58	71.23	1.72	0.43
occipital pole, adult, pool1	10036-101E9	0.00	30.20	1.10	0.39
olfactory region, adult	10195-103E6	0.19	31.14	2.48	0.19
optic nerve, donor1	10277-104E7	0.00	48.03	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	18.45	38.39	2.51	1.94
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	79.27	7.83	0.27	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	30.99	10.50	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	71.50	10.97	0.12	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	6.17	37.04	2.06	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.98	15.88	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	57.89	29.69	2.54	1.48
ovary, adult, pool1	10020-101D2	0.79	27.60	0.52	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	13.57	12.10	0.37	0.18
pancreas, adult, donor1	10049-101G4	0.94	27.28	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	80.23	23.48	3.07	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	42.25	26.75	1.19	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	40.57	24.84	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	0.18	37.89	2.20	0.27
parietal cortex, adult, donor10258	10373-105G4	1.47	28.63	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	0.00	37.62	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	0.29	30.21	2.85	0.86
parietal lobe, adult, pool1	10034-101E7	0.18	40.36	1.59	0.35
parietal lobe, fetal, donor1	10072-101I9	24.25	41.70	3.88	0.00
parietal lobe, newborn, donor10223	10356-105E5	0.37	15.33	2.62	0.75
parotid gland, adult	10199-103F1	1.85	43.78	0.00	0.00
penis, adult	10200-103F2	2.15	28.47	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.04	16.18	1.86	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	60.17	16.90	0.87	0.58
pineal gland - adult, donor10196	10179-103C8	0.65	34.83	2.58	0.00
pineal gland, adult, donor10252	10160-103A7	1.18	64.55	3.55	0.59
pineal gland, adult, donor10258	10377-105G8	0.00	47.03	3.76	0.00
pituitary gland - adult, donor10196	10180-103C9	0.00	51.60	3.04	0.00
pituitary gland, adult, donor10252	10162-103A9	0.00	62.54	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	0.00	79.17	0.00	0.85
placenta, adult, pool1	10021-101D3	9.03	23.97	0.65	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	202.08	25.82	0.93	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.19	21.79	0.16	0.00
pons, adult, pool1	10033-101E6	0.09	30.64	2.07	0.09
postcentral gyrus, adult, pool1	10032-101E5	0.52	37.05	1.48	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	75.29	31.37	39.74	8.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	308.45	88.13	16.52	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	492.90	105.62	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	165.62	46.03	0.73	0.29
prostate cancer cell line:PC-3	10439-106E7	87.12	20.69	0.73	0.36
prostate, adult, pool1	10022-101D4	1.09	41.54	1.00	0.27
putamen, adult, donor10196	10176-103C5	0.47	55.47	1.89	0.47
putamen, adult, donor10252	10152-102I8	1.96	72.55	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	60.10	14.21	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	0.72	51.22	1.21	0.24
putamen, newborn, donor10223	10365-105F5	0.75	14.24	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	23.86	8.44	0.00	0.00
rectum, fetal, donor1	10067-101I4	41.73	65.38	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	56.18	30.32	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	3.31	27.34	0.00	0.00
retina, adult, pool1	10030-101E3	0.50	48.21	1.19	0.60
retinoblastoma cell line:Y79	10475-106I7	219.53	39.23	3.90	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	109.79	33.81	0.37	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	167.03	15.18	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	5.30	15.91	0.00	0.76
salivary acinar cells, donor1	11771-123I7	10.52	20.07	0.16	0.16
salivary acinar cells, donor2	11772-123I8	7.02	30.98	1.10	0.28
salivary acinar cells, donor3	11773-123I9	0.66	19.20	0.00	0.00
salivary gland, adult, pool1	10093-102C3	5.15	22.31	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	12.82	18.72	0.17	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	15.40	30.45	0.24	0.00
seminal vesicle, adult	10201-103F3	0.00	34.39	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	29.88	18.95	2.19	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	5.54	21.39	1.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	65.23	15.05	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	8.19	13.16	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	50.73	13.93	0.66	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	55.87	17.42	0.13	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	0.00	10.64	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	0.60	20.39	1.08	0.12
skeletal muscle, fetal, donor1	10066-101I3	6.03	25.13	1.01	0.00
skin, adult, donor1	10074-102A2	6.79	33.93	0.00	0.00
skin, fetal, donor1	10065-101I2	21.46	49.24	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	182.77	35.69	1.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	164.54	53.90	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	89.24	33.15	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	143.89	41.54	1.15	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	122.73	24.93	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	121.82	29.85	1.53	0.65
small intestine, adult, pool1	10024-101D6	8.84	18.16	0.24	0.24
small intestine, fetal, donor1	10064-101I1	24.82	40.29	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	43.60	22.05	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	0.52	29.98	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	5.90	17.42	1.88	0.54
spinal cord - adult, donor10196	10181-103D1	0.00	40.15	2.06	0.69
spinal cord, adult, donor10252	10159-103A6	1.58	38.64	0.79	0.79
spinal cord, adult, donor10258	10369-105F9	0.69	37.36	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	9.76	67.08	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	1.38	25.26	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	25.09	16.88	1.49	0.45
spleen, adult, pool1	10025-101D7	17.40	20.71	0.99	0.11
spleen, fetal, pool1	10044-101F8	27.81	20.10	0.72	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	69.25	21.22	0.72	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	15.76	13.48	0.95	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	32.85	11.88	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	1.17	8.21	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	22.51	11.37	1.58	1.46
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	153.34	21.60	0.42	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	91.38	27.92	0.00	0.42
stomach, fetal, donor1	10062-101H8	11.75	13.88	0.00	0.00
submaxillary gland, adult	10202-103F4	0.00	40.45	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	1.25	41.54	1.04	0.21
substantia nigra, adult, donor10258	10371-105G2	4.14	26.38	2.07	0.52
substantia nigra, newborn, donor10223	10358-105E7	0.00	14.84	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	147.65	44.48	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	0.25	35.35	2.20	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	13.53	63.39	3.56	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	15.82	34.28	0.44	1.32
tenocyte, donor1	11763-123H8	36.66	21.99	0.35	0.35
tenocyte, donor2	11765-123I1	11.83	41.58	2.29	0.76
tenocyte, donor3	11768-123I4	40.40	27.43	1.11	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	121.01	16.66	2.04	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	109.91	17.42	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	103.99	17.20	1.70	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	43.42	10.92	0.38	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	25.34	13.24	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	6.22	5.67	2.07	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	27.68	5.86	1.30	0.33
testis, adult, pool1	10026-101D8	9.34	29.74	2.79	0.75
testis, adult, pool2	10096-102C6	37.89	27.52	8.12	0.45
thalamus - adult, donor10196	10168-103B6	0.00	38.64	1.10	1.10
thalamus, adult, donor10252	10154-103A1	0.31	36.88	0.78	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	0.00	26.17	4.62	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	0.33	42.65	1.15	0.00
thalamus, newborn, donor10223	10366-105F6	0.00	13.81	0.58	0.58
throat, adult	10209-103G2	12.48	30.46	0.50	0.00
throat, fetal, donor1	10061-101H7	18.59	54.85	1.22	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	89.03	19.67	0.00	0.00
thymus, adult, pool1	10027-101D9	148.53	29.73	4.57	2.58
thymus, fetal, pool1	10043-101F7	75.64	27.85	4.57	2.29
thyroid carcinoma cell line:KHM-5M	10776-110G2	96.53	20.34	0.80	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	109.66	40.93	0.56	0.14
thyroid, adult, pool1	10028-101E1	0.65	63.55	0.56	0.37
thyroid, fetal, donor1	10060-101H6	9.49	74.35	1.58	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	21.56	0.00	0.00
tongue, adult	10203-103F5	20.47	26.28	0.23	0.00
tongue, fetal, donor1	10059-101H5	14.58	57.54	0.39	0.00
tonsil, adult, pool1	10047-101G2	41.97	31.66	0.80	0.30
trachea, adult, pool1	10029-101E2	5.89	24.29	0.65	0.41
trachea, fetal, donor1	10058-101H4	6.92	46.55	1.92	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	48.54	14.88	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	43.77	13.88	1.01	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	54.21	37.60	0.31	0.16
tridermal teratoma cell line:HGRT	10694-109G1	41.86	11.42	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	2.62	21.67	0.76	0.08
umbilical cord, fetal, donor1	10057-101H3	8.35	20.87	0.00	0.00
uterus, adult, pool1	10100-102D1	2.22	25.94	0.34	0.34
uterus, fetal, donor1	10055-101H1	27.64	60.41	1.02	0.00
vagina, adult	10204-103F6	0.00	21.97	0.00	0.00
vein, adult	10191-103E2	16.44	29.37	0.66	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	69.16	25.64	0.80	0.53